Health and Healthcare
5864 Articles
TransEnterix has announced that the FDA notified it that its SurgiBot System does not meet the criteria for substantial equivalence…
American Renal Associates expects to price more than 7 million shares in the range of $20 to $23 per share…
BioMarin Pharmaceutical is ready to break above the $1 billion revenue barrier in 2016, a feat that marks a major…
Spectrum Pharmaceuticals announced that the FDA has granted seven years of Orphan Drug exclusivity for Evomela.
Cara Therapeutics saw its shares jump early on Wednesday after it announced that it has received notice from the FDA…
Gemphire Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Johnson & Johnson reported better-than-expected first-quarter 2016 results before markets opened Tuesday morning.
UnitedHealth Group reported better-than-expected first-quarter 2016 results before markets opened Tuesday morning.
According to The Wall Street Journal, the reasons Theranos may lose all of its value have been bolstered by an…
New research from Jefferies highlights this week's top growth stock picks, and there is a clear bias for some top…
Shares of Clovis Oncology dropped after the FDA Oncologic Drugs Advisory Committee voted against its lung cancer drug.
PTC Therapeutics saw its shares jump late Friday morning on positive news on its nonsense mutation Duchenne muscular dystrophy treatment.
Valeant Pharmaceuticals got another dose of bad news Thursday morning. Standard & Poor's Ratings Services dropped the Canadian drugmaker's corporate…
The March 31 short interest data have been compared with the previous report, and short interest decreased across the board…
The March 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…
Our top personal finance-related articles today. Your wallet will thank you later.